−£1,042
vs Sept 2023Active12219495Private limited companyLondon
NR PHARMA LTD
E17/10001
Summary
NR PHARMA LTD is an active private limited company (company number 12219495) incorporated on 21 September 2019, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 30 September 2024, showing net assets of −£1,042 and cash of £17k, with 0 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 56% on the prior period (−£670).
Peer position · net assets
By net assets it sits in the bottom quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Key dates
- Incorporated
- 21 September 20197 yrs ago
- Next accounts due
- 30 June 2026114 days overdue
- Confirmation statement due
- 5 October 2027in 348 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 47749
- Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.
- SIC 86210
- General medical practice activities
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
04
Financials
£17k
−84%vs Sept 2023Not disclosed
0
vs Sept 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2024 | −£1,042 | £17k | — | £139k | — | — | 0 |
| 30 September 2023 | −£670 | £107k | — | £230k | — | — | 0 |
Current ratio0.13Current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
17 / 100 · grade E
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-1,042 at 2024-09-30 |
| −8 | Net assets falling-55.5% vs prior period |
| −8 | Current liabilities exceed current assetsCurrent ratio 0.13 |
| +8 | EstablishedIncorporated 2019-09-21 (7 years) |
| −10 | Accounts overdueDue 2026-06-30 |
| 17 | Score, grade E |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr Nyanga Lovemore
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Maria Jose Hijazo Ros
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 348 days
- Next accounts due114 days overdue
- Accounts period endNet liabilities £1,042 · abridged accounts
- Accounts period endNet liabilities £670 · abridged accounts
- Incorporated
08
Similar companies in London
- WORLD PHARMA LIMITEDLondon · inc. Sept 2019
- MEDI TYNE CARE LTDLondon · inc. Oct 2019
- BLOOMSNANO LIMITEDLondon · inc. Oct 2019
- ECS PHARMA LIMITEDLondon · inc. Aug 2019
- VITABIOTICS DISTRIBUTION LTDLondon · inc. Aug 2019
- INNOPEUTICS LTDLondon · inc. Jul 2019
All companies incorporated on 21 September 2019 · in Sept 2019.
09
Reminders for NR PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.